Implications of chronic obstructive pulmonary disease (COPD) on patients' health status: A western view

Respiratory Medicine

Volumn 101, Issue 3, 2007, Pages 661-669

  Punekar, Yogesh Suresh ^a   Rodriguez Roisin, Roberto ^b   Sculpher, Mark ^c   Jones, Paul ^d   Spencer, Michael ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF YORK   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Comparison; COPD; Country; Health status; Treatment

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; DYSPNEA; EUROPE; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HEALTH STATUS; HEALTH SURVEY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL SPECIALIST; MORTALITY; PAIN; PHYSICAL ACTIVITY; PHYSICIAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; UNITED STATES;

AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DISTRIBUTION; UNITED STATES;

EID: 33846815220     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.001     Document Type: Article

References (18)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report April 2001(Updated 2005).
2. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 9064 (1997) 1498-1504
3. Murray CJ, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 Project: global program on evidence for health policy discussion, paper number 36. Geneva: WHO; 2001.
4. Department of Commerce. Statistical abstract of the United States, 1997. US Department of Commerce, Bureau of the Census. Washington, DC, 1997.
5. Mannino D.M., Brown C., and Giovino G.A. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 156 3 Part 1 (1997) 814-818
6. Wouters E. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 97 Suppl C (2003) S3-S14
7. Jones P. Issues concerning health-related quality of life in COPD. Chest 107 Suppl 5 (1995) 187S-193S
8. EuroQoL Group. EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy 16 3 (1990) 199-208
9. Brooks R., and EuroQol group. EuroQol: the current state of play. Health Policy 37 1 (1996) 53-72
10. Rabin R., and de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33 5 (2001) 337-343
11. Bestall J., Paul E., Garrod R., Garnham R., Jones P., and Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 7 (1999) 581-586
12. Dolan P. Modelling valuations for EuroQol health status. Med Care 35 11 (1997) 1095-1108
13. Charlson M., Pompei P., Ales K., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 5 (1987) 373-383
14. Shaw J., Johnson J., and Coons S. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43 3 (2005) 203-220
15. Badia X., Roset M., Herdman M., and Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21 1 (2001) 7-16
16. Curtis J., and Patrick D. The assessment of health status among patients with COPD. Eur Respir J Suppl. 41 (2003) 36s-45s
17. Stavem K., and Jodalen H. Reliability and validity of the COOP/WONCA health status measure in patients with chronic obstructive pulmonary disease. Qual Life Res 11 6 (2002) 527-533
18. Brazier J., Roberts J., Tsuchiya A., et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13 9 (2004) 873-884